Open Access

Differential effect of Pistacia vera extracts on experimental atherosclerosis in the rabbit animal model: an experimental study

  • Katerina A Marinou1, 2,
  • Katerina Georgopoulou3,
  • George Agrogiannis4,
  • Theodore Karatzas1, 5,
  • Dimitrios Iliopoulos1,
  • Apostolos Papalois6,
  • Achilles Chatziioannou7,
  • Prokopios Magiatis3,
  • Maria Halabalaki3,
  • Nektaria Tsantila8,
  • Leandros A Skaltsounis3,
  • Efstratios Patsouris4 and
  • Ismene A Dontas1, 9Email author
Lipids in Health and Disease20109:73

https://doi.org/10.1186/1476-511X-9-73

Received: 29 March 2010

Accepted: 16 July 2010

Published: 16 July 2010

Abstract

Background

Lipid-enriched diets and oxidative stress are risk factors for the development of atherosclerosis. The effects of the methanolic (ME) and cyclohexane (CHE) extracts of the Pistacia vera nut, often included in the Mediterranean diet, were studied in the rabbit model of atherosclerosis.

Methods and results

Twenty-four New Zealand White rabbits received atherogenic diet (Control Group), supplemented with ME (Group ME) or CHE (Group CHE) for 3 months. Previously, a GC-MS and a UHPLC LC-DAD-ESI(-)-HRMS/MS method were developed to investigate the extracts' chemical profiles. Blood samples at baseline and monthly determined lipid profile, lipid peroxidation and liver function. The aorta, myocardium and liver were examined histologically at 3 months.

Groups ME and CHE had significantly higher HDL- and non-significantly lower LDL-cholesterol median % changes from baseline than the Control Group. Triacylglycerol was significantly higher in Group CHE vs. Control. MDA values were significantly lower in Group ME vs. Control and CHE. ALT and AST were significantly higher in Group CHE vs. Control. γ-GT was lower in Group ME vs. Control. Aortic intimal thickness was significantly less in Groups ME and CHE vs. Control; Group ME atherosclerotic lesions were significantly less extensive vs. Groups Control and CHE. Only Group CHE had significant liver fatty infiltration.

Conclusions

During short-term administration concomitantly with atherogenic diet, both P. vera extracts were beneficial on HDL-, LDL-cholesterol and aortic intimal thickness. The ME additionally presented an antioxidant effect and significant decrease of aortic surface lesions. These results indicate that P. vera dietary inclusion, in particular its ME, is potentially beneficial in atherosclerosis management.

Background

Cardiovascular disease is the leading cause of mortality in the industrialized part of the world with atherosclerosis being its primary manifestation [1]. The development and progression of atherosclerotic lesions has been studied extensively. Many clinical studies have been performed regarding dietary protocols, such as the Seven Countries study on Mediterranean diet which includes olive oil [2]. Other clinical studies have involved pharmaceutical [3] and surgical interventions alone [4], or in combination [5]. Scientific evidence for the pathogenesis and therapy of atherosclerosis during the last century has derived to a large extent from research protocols on animal models.

The rabbit, one of the most important models for the study of atherosclerosis, rapidly responds to the inducement of atherosclerotic lesions through a high cholesterol diet [6]. Several dietary studies have used this model, including the administration of olive or fish oil and different seed extracts or oils, derived from sunflower seeds, peanuts, flaxseeds or hazelnuts [710]. An edible nut, consumed either alone or as an ingredient in traditional recipes, is the pistachio nut from the tree Pistacia vera, which belongs to the Anacardiaceae family and is distributed in central and southeastern Greece, as well as other Mediterranean and Middle East countries. To our knowledge, only in vitro studies are published regarding its bioactive effect on the development of atherosclerosis [11]. We, therefore, sought to investigate the effect of P. vera cyclohexane (CHE) and methanolic extract (ME) administration on the rabbit experimental model of atherosclerosis on serum biochemistry, as well as aortic, heart and liver lesions.

Results

In Table 1 the descriptive statistics of the measured parameters of the 3 Groups are shown. Table 2 shows median % changes from baseline of body weight, lipid profile and antioxidant status biochemical parameters and the overall statistical significances. Table 3 shows median % changes from baseline of liver enzymes activity and the overall statistical significances. Table 4 shows morphometric analysis on rabbit aortas.
Table 1

Descriptive statistics: mean values ± standard deviation of body weight and biochemical parameters

 

Baseline

1st month

2nd month

3rd month

Group Control

WEIGHT (Kg)

3.17 ± 0.21

3.46 ± 0.18

3.54 ± 0.27

3.49 ± 0.19

TC (mg/dL)

67.88 ± 5.66

649.88 ± 44.4

987.13 ± 95.00

1347.00 ± 149.33

HDL-C (mg/dL)

24.62 ± 2.38

62.37 ± 17.20

59.875 ± 20.95

46.37 ± 4.20

LDL-C (mg/dL)

23.72 ± 4.82

555.7 ± 46.54

854.62 ± 83.41

1146.60 ± 159.25

TAG (mg/dL)

97.63 ± 12.93

159 ± 24.96

363.13 ± 26.28

770.13 ± 68.48

MDA (nmol/L)

1.14 ± 0.14

1.74 ± 0.19

2.22 ± 0.16

3.47 ± 0.47

ALT (IU/L)

7.75 ± 2.12

15.37 ± 3.46

24.38 ± 3.30

37.25 ± 5.42

AST (IU/L)

11.75 ± 2.87

33.38 ± 8.30

42.00 ± 6.05

47.75 ± 6.69

γGT (IU/L)

14.25 ± 2.71

47.13 ± 13.42

77.00 ± 15.23

215.13 ± 67.34

Group ME

WEIGHT (Kg)

3.09 ± 0.19

3.24 ± 0.26

3.37 ± 0.15

3.40 ± 0.14

TC (mg/dL)

55.75 ± 11.67

697.63 ± 75.20

881.25 ± 66.00

1130.5 ± 146.07

HDL-C (mg/dL)

19.75 ± 4.65

57.125 ± 23.27

76.875 ± 15.62

57.62 ± 15.26

LDL-C (mg/dL)

23.15 ± 9.16

602.82 ± 84.69

740.52 ± 56.36

958.22 ± 146.61

TAG (mg/dL)

64.25 ± 9.42

188.38 ± 49.20

319.25 ± 38.53

573.25 ± 63.15

MDA (nmol/L)

1.12 ± 0.09

1.99 ± 0.27

2.73 ± 0.33

3.50 ± 0.71

ALT (IU/L)

8.25 ± 2.25

20.88 ± 5.05

33.88 ± 4.97

49.88 ± 4.26

AST (IU/L)

16 ± 13.53

39.38 ± 15.36

49.63 ± 16.63

59.63 ± 13.8

γGT (IU/L)

16.13 ± 3.78

42.5 ± 10.90

127.13 ± 16.37

161.88 ± 66.13

Group CHE

WEIGHT (Kg)

3.17 ± 0.22

3.50 ± 0.27

3.50 ± 0.28

3.52 ± 0.37

TC (mg/dL)

65.87 ± 11.59

670.13 ± 52.56

979.50 ± 173.68

1477.13 ± 190.83

HDL-C (mg/dL)

16.62 ± 4.00

78.75 ± 7.89

87.75 ± 6.60

68.75 ± 17.88

LDL-C (mg/dL)

33.22 ± 11.43

543.62 ± 44.61

807.82 ± 170.22

1234.62 ± 181.51

TAG (mg/dL)

80.13 ± 13.55

238.75 ± 46.40

419.63 ± 46.55

868.75 ± 224.28

MDA (nmol/L)

1.13 ± 0.10

1.97 ± 0.33

2.54 ± 0.41

4.19 ± 1.02

ALT (IU/L)

8.25 ± 4.10

23.00 ± 5.55

36.25 ± 6.54

60.87 ± 17.45

AST (IU/L)

14.00 ± 4.00

46.12 ± 11.09

57.37 ± 17.68

86.00 ± 8.83

γGT (IU/L)

18.50 ± 3.02

43.87 ± 13.44

124.87 ± 12.50

217.37 ± 25.12

Mean values regarding body weight, lipid profile and oxidative stress during the observation period in the three Groups: Control (atherogenic diet), ME (atherogenic diet plus ME), CHE (atherogenic diet plus CHE).

All variables are presented as mean ± SD

Table 2

Percent changes of body weight, lipid profile and oxidative stress in rabbit serum

 

Group

% change

baseline - 1st month

% change

baseline - 2nd month

% change

baseline - 3rd month

RABBIT WEIGHT (Kg)

Control

9.71

12.91

8.99

 

ME

5.05

9.72

9.47

 

CHE

7.74

11.80

10.76

 

Overall Sig

NS

NS

NS

TC (mg/dL)

Control

830.55

1351.17

1941.41

 

ME

1155.48a

1523.27

2018.04

 

CHE

865.03b

1396.17

2330.76

 

Overall Sig

< 0.0005

NS

NS

HDL-C (mg/dL)

Control

189.74

185.74

81.55

 

ME

163.33

262.98a

212.42a

 

CHE

344.74a b

350.00a b

294.74a

 

Overall Sig

< 0.0005

< 0.0005

< 0.0005

LDL-C (mg/dL)

Control

2124.53

3148.05

4876.60

 

ME

2355.51

3239.36

4301.47

 

CHE

1524.47a b

2403.38a

4011.39

 

Overall Sig

< 0.0005

< 0.0005

NS

TAG (mg/dL)

Control

56.43

275.45

708.35

 

ME

200.00a

388.28a

810.75

 

CHE

188.18a

356.43a

927.84a

 

Overall Sig

< 0.0005

< 0.0005

< 0.0005

MDA (nmol/L)

Control

50.19

91.93

196.37

 

ME

64.71a

70.26

160. 51a

 

CHE

73.71

146.43b

297.85b

 

Overall Sig

< 0.0005

0.032

0.012

Median % change from baseline in body weight, lipid profile and oxidative stress values during the observation period in the three Groups: Control (atherogenic diet), ME (atherogenic diet plus ME), CHE (atherogenic diet plus CHE).

a Significant difference for p < 0.05, compared to Control Group

b Significant difference for p < 0.05, compared to Group ME

Overall Sig: Overall significance, NS: Non-significant

Table 3

Percent changes of liver enzyme activities in rabbit serum

 

Group

% change

baseline-1st month

% change

baseline-2nd month

% change

baseline-3rd month

ALT (IU/L)

Control

105.00

202.14

350.71

 

ME

163.89

327.22a

448.89

 

CHE

198.57a

429.76a

648.81a

 

Overall Sig

0.002

0.005

0.001

AST (IU/L)

Control

167.53

247.08

300.32

 

ME

268.18

415.15

472.73

 

CHE

250.77

382.05

569.23a

 

Overall Sig

NS

NS

0.018

γGT (IU/L)

Control

231.94

436.90

1345.75

 

ME

183.59

650.38a

855.06a

 

CHE

123.68a

561.40a

1227.86b

 

Overall Sig

< 0.0005

< 0.0005

< 0.0005

Median liver enzyme activity % change from baseline during the observation period in the three Groups. Control Group: atherogenic diet, Group ME: atherogenic diet plus ME, Group CHE: atherogenic diet plus CHE

a Significant difference for p < 0.05, compared to Control Group

b Significant difference for p < 0.05, compared to Group ME

Overall Sig: Overall significance, NS: Non-significant

Table 4

Morphometric analysis on rabbit aortas

Group

thickness (mm)

surface area (mm2/mm)

Control (n = 8)

0.883 ± 0.199

0.932 ± 0.161

ME (n = 8)

0.152 ± 0.128a

0.256 ± 0.159a

CHE (n = 8)

0.468 ± 0.222a b

0.864 ± 0.205b

Results are expressed as median ± SD.

Control Group: atherogenic diet, Group ME: atherogenic diet plus ME, Group CHE: atherogenic diet plus CHE

a Significant difference for p < 0.05, compared to Control Group

b Significant difference for p < 0.05, compared to Group ME

Body weight

The final median % change from baseline in Groups Control, ME and CHE was not statistically significant (Table 2), although a mild increase in absolute mean values was observed (Table 1).

Biochemical values

Plasma lipid levels

Plasma lipid levels of all three Groups were similar at baseline. The median % changes from baseline during the observation period described below are shown in Table 2.

TC

The median % change from baseline to 1st month for Groups ME and CHE was statistically significantly higher compared to the Control Group (p = 0.01 and 0.05 respectively).

HDL-C

The median % change of Group CHE was statistically significantly higher compared to Groups Control and ME at the 1st and 2nd months, while Groups ME and CHE had statistically significant higher values than the Control Group in the 2nd (p = 0.001 and p < 0.005 respectively) and 3rd month (p = 0.01, p < 0.005 respectively).

LDL-C

The median % change of Group CHE was statistically significantly lower compared to the Control Group, in the 1st and 2nd month (p < 0.005), while the median % change of Group CHE was statistically significantly lower compared to Group ME only in the 1st month (p = 0.038).

TAG

The median % change of Group ME was statistically significantly higher compared to the Control Group in the 1st and 2nd month (p < 0.005 and p = 0.001 respectively). The % change of Group CHE values was significantly higher than those of the Control Group throughout the study (p < 0.005, p = 0.003 and p = 0.05 respectively).

Antioxidant evaluation

MDA

The median % change of Group CHE was statistically significantly higher compared to Group ME in the 2nd and 3rd month (p = 0.032 and 0.012 respectively). Moreover the median % change of Group ME was statistically significantly different compared to the Control Group in the 1st and 3rd month (p < 0.0005 and p = 0.032 respectively).

Liver function

ALT

The median % change of Group ME was statistically significantly higher compared to the Control Group in the 2nd month (p = 0.05), while the median % change of Group CHE compared to the Control Group was significantly higher throughout the study (p < 0.05).

AST

The median % change of plasma values of all Groups did not show a statistically significant increase during the whole experimental period with Group CHE having higher values only in the 3rd month (p = 0.007).

γGT

The median % change of Group ME values was statistically significant lower compared to Groups Control and CHE in the 3rd month of the experiment (p < 0.005).

Tissue pathology

Aorta

Aortic macroscopic specimens from Groups Control and CHE showed extensive atherosclerotic plaques covering almost the whole upper part of the excised aorta (Table 4 and Fig. 1A and 1E). Group ME specimens showed less extensive lesions compared to Group A, as well as compared to Group CHE (Table 4 and Fig. 1C).
Figure 1

Macro- and microscopic images of representative aortas from rabbits of the three Groups. 1A, 1C, 1E are representative images from the gross aortic specimens belonging to Groups Control, ME and CHE, respectively. Arrows indicate atherosclerotic plaque formations. As depicted, the Control Group exhibited extensive atherosclerotic plaques covering almost the whole upper part of the excised aorta. Groups ME and CHE exhibited less extensive lesions compared to Control Group, and between these two groups, Group ME had the least lesion formation. 1B, 1D, 1F are microphotographs from 1A, 1C, 1E respectively (eosin - hematoxylin, original magnification ×100). Figure 1B (of Control Group) shows a vulnerable plaque with many foam cells, inflammation and remarkable intimal thickening. Figure 1D (Group ME) shows the above described lesion, but less extensive (intima/media ratio thickness is less than in 1B. Figure 1F (Group CHE) demonstrates aortic endothelium with evidence of thickening and many foam cells, however the intima/media ratio is less than in 1B. Arrows indicate the width of the endothelium.

Histopathological findings from Group Control and CHE showed vulnerable plaques with many foam cells, inflammation and remarkable intimal thickening (Fig. 1B and 1F). In Group ME the above described lesions, but less extensive, were detected (Fig. 1D).

Heart and liver

Histological examination of the heart did not reveal significant changes between Groups.

Histological examination of the liver did not reveal significant changes between Groups Control and ME. Group CHE presented statistically significant fatty infiltration compared to the Control Group.

Discussion

The non-genetic hyperlipidemic rabbit is an animal model widely used in atherosclerosis studies. Various levels of dietary cholesterol (0.2-1.3%) have been used to create the disease experimentally [12, 13] and concomitant administration of other potentially beneficial substances has been studied for periods varying from 8 [12] up to 14 weeks [10, 12].

The Pistacia plants are trees or bushes indigenous to Greece and other Mediterranean and Middle East countries. Among their 11 species, P. lentiscus has been shown to have antioxidant [14], antibacterial [15, 16], liver-protective [17] and cytostatic [14] effects and to prevent human LDL-cholesterol from oxidation in vitro[18]. P. terebinthus has been demonstrated to have a beneficial action on uterine condylomata and skin melanomas [14]. Few studies have been carried out on P. vera. It has been reported to have plant antifungal effects [19]. P. vera ME contains small quantities of catechin, a polyphenolic flavonoid that shows potentially higher antioxidant activity than ascorbic acid and α- tocopherol in in vitro studies [20]. Catechin and its products have also been indicated as factors of reducing cardiovascular risk by lowering serum cholesterol levels, diminishing platelet aggregation and reducing blood pressure [21].

In the present study we investigated the effect of the co-administration of P. vera, on the progress of cholesterol-induced atherosclerosis of the rabbit animal model for 12 weeks. We chose to administer the ME or CHE of P. vera separately in different animal groups, in order to be able to identify which components would be responsible for the potentially different results. GC-MS analysis of the CHE showed that its major compounds are b-sitosterol, squalene, stigmasterol, oleic and palmitic acid. Clinical trials have already shown the protective effects of such plant sterols in the development of coronary heart disease [22]. Furthermore, analysis of the ME using LC-HRMS/MS techniques revealed the presence of gallic methyl ester, protocatechuic acid and gallic acid. Gallic acid has been demonstrated to have antiatherogenic activity [23].

The results of the present study show a beneficial effect of the co-administration of the P. vera ME and CHE in cholesterol enriched diet on HDL-C changes. ME also demonstrated less MDA change from baseline, revealing thus a mild antioxidant effect. The LDL-C beneficial effect of ME was not statistically significant. The other biochemical parameters examined (TC, TAG and liver enzymes), did not demonstrate a beneficial effect of the ME with the analysis of data using % change median values. The analysis of our data using mean absolute values showed a statistically significant protective effect of the ME on the above parameters (Table 1). However, because of the lack of normal distribution of the values, use of the non-parametric analysis (Kruskal-Wallis and Mann-Whitney tests) was deemed necessary.

Several plant substances have a beneficial effect on blood biochemistry of cholesterol-fed rabbits. The olive oil polyphenol known as hydroxytyrosol increased the HDL-C levels of atherogenic diet-fed rabbits [13]. Sesame flour had a beneficial effect on the total cholesterol and triglyceride levels of cholesterol-fed rabbits [24]. Also, secoisolariciresinol diglucoside (SDG), a plant lignan isolated from flaxseed when administered to rabbits for 8 weeks resulted in a decrease of LDL-C and an increase in HDL-C and antioxidant activity [9], similarly to our study. Furthermore, another study in rabbits using ethanol extract of Hypericum lysimachioides Boiss var lysimachioides (Guttifera), showed a statistically significant decrease of MDA levels, as well as an increase of HDL-C levels, in agreement with our study [25].

Our results showed that treatment with both extracts of P. vera induces a mild increase in TC values, although this is not significantly different from the Control Group in the second and third month of administration.

HDL-C median values in the Control Group were lower at the end of the experiment, whereas the co-administration of P. vera extracts (Groups ME and CHE) significantly inhibited this decrease. Considering that low HDL-C is associated with a higher risk of cardiovascular disease, it is supported that increased HDL-C will result in a protective effect against atherosclerosis, after prolonged administration of the P. vera extracts.

Our results showed significant differences in plasma MDA levels between the ME and the Control Groups. This suggests that the P. vera ME's beneficial effect on some lipids and the aorta may be due to a mild anti-oxidant effect.

In our study, liver enzyme levels increased reaching maximum levels the third month in all groups. Specifically, ALT and AST changes were increased in Groups ME and CHE compared to Control. Both clinical and experimental studies have demonstrated that elevated ALT and AST can be predictive for the development of atherosclerosis [26, 25]. Furthermore, γGT changes of Group ME were statistically significantly lower in the third month compared to the Control Group. This is indicative of a beneficial effect of the P. vera ME and CHE in the function of the biliary system of atherosclerotic animals. In the study by Hakimoglu et al. [25] liver hydropic and lipid degeneration was decreased in ethanol extract of Hypericum lysimachoides compared to that of the rabbits fed only with cholesterol enriched diet. This finding is similar to ours, where the liver histology of ME fed rabbits was less affected than the cholesterol group (Control), although there was no statistically significant difference. Specifically, the Control Group rabbits suffered from hepatic damage characterised by steatosis and fibrosis, which was even more evident in Group CHE.

Macroscopically plaque formation in Group ME was less extensive compared to Groups Control and CHE. Similarly to our study, other researchers have observed that despite increase of serum cholesterol after the administration of an extract, the pathology results of the aortic specimens may show an amelioration of the progress of atherosclerosis [27]. Aguilera et al. [8] found that virgin olive oil and fish oils reduce the development of atherosclerotic plaques. Hazelnut oil has also been shown to reduce atherosclerotic lesions in the aorta of cholesterol fed rabbits [10]. In addition, the effect of green tea administration containing epicatechin derived compounds in rabbits showed a beneficial effect on the arterial atherosclerotic plaques [28]. This is in agreement with our findings, which indicated a significant beneficial effect of the P. vera ME on the development of aortic atherosclerosis. Specifically, Group ME presented significant inhibition of atherosclerotic plaques regarding both their thickness and extent within the aortic lumen. This may be attributed to the major ME components, such as gallic acid and catechin that may be responsible for this inhibition process as already indicated [22, 28]. On the other hand, Group CHE exhibited milder atherosclerosis inhibition regarding plaque thickness, which can be attributed to the presence of b-sitosterol, squalene, stigmasterol, oleic and palmitic acid, as similarly shown [29, 30].

Group CHE exhibited the lowest antioxidant activity. This effect can possibly be linked to the extensive but not so complicated atherosclerotic lesions observed in Group CHE aortic specimens compared to those of Groups Control and ME. Group ME, however, exhibited a much stronger antioxidant activity. The statistically significant observed antioxidant effect of the ME, evident by the MDA analysis, concomitantly decreased aortic plaque deposition significantly. On the other hand, the CHE did not affect the extent of atherosclerotic lesions. These findings may be attributed to P. vera ME constituents exerting antioxidant activity [11].

Conclusions

In conclusion, during short-term administration concomitantly with atherogenic diet, both P. vera extracts were beneficial on HDL-, LDL-cholesterol and aortic intimal thickness. The ME additionally presented an antioxidant effect and significant decrease of aortic surface lesions. These results indicate that P. vera dietary inclusion, in particular its ME, may potentially be beneficial in atherosclerosis management. P. vera ME and CHE are being used in vivo for the first time to our knowledge in the study of atherosclerosis and show a promising effect regarding its inhibition process. More research is required before P. vera may be clinically recommended for dietary inclusion for atherosclerosis management.

Methods

Animals

Twenty-four conventional male New Zealand White rabbits (2.7 ± 0.2 Kg), purchased from a Greek approved commercial breeder, were randomly divided into three equal groups (Control, ME and CHE) and kept singly in stainless steel cages with free access to food and tap water. The animal house conditions consisted of 20 ± 2°C, 60 ± 5% relative humidity, under a 12:12 h light: dark cycle. The animals were handled according to standards imposed by the European Directive 86/609/EEC. The local veterinary authorities and animal ethics committee approved (License No. K/950) the study. The Control Group received standard rabbit balanced diet (chemical composition: total fatty acids 2.5%, cellulose 18.5%, total protein 16.5%, water 13%, ash 11%, calcium 1.4%, lysine 0.6%, methionine-cystine 0.55%, phosphorus 0.55%, sodium 0.25%) enriched with 1% cholesterol (Dolder, Switzerland) (atherogenic diet), Group ME received atherogenic diet plus ME (1% v/w) and Group CHE atherogenic diet plus CHE (5% v/w). Diets were freshly prepared every three days before use.

Preparation and analysis of the extracts

Cyclohexane Extract of P. vera (CHE)

A quantity of 15 Kg powdered pistachio nuts collected in the Greek island of Aegina was extracted at room temperature, first to be defatted with cyclohexane, giving 7.5 Kg of a green oil residue after evaporation of the solvent. The CHE was saponified by the usual procedure resulting to esterified fatty acids. The fatty acid methylesters of the oils and the unsaponified residue were analyzed by GC and GC/MS to afford b-sitosterol, squalene, stigmasterol, oleic acid and palmitic acid as major compounds (see Additional file 1).

Methanolic Extract of P. vera (ME)

After the extraction of powdered pistachio nuts with cyclohexane, the plant material was further extracted with dichloromethane giving 1.5 Kg of green oily extract and then with methanol to give a residue of 500 g after evaporation of the solvent. A quantity of 400 g of the residue was subjected to XAD-4 resin for sugar removal and a ME enriched in phenolic compounds was obtained. In order to describe the chemical profile of the enriched extract a LC-DAD-ESI(-)-HRMS/MS method was developed. The analysis was performed using a UHPLC apparatus connected to the high resolution hybrid LTQ-Orbitrap Discovery spectrometer. The phenolic compounds, gallic methyl ester (1), gallic acid (2), protocatechuic acid (3) catechin (4) and epicatechin (5) were used as standards for the analysis and the identification thereof was accomplished by comparing the retention time, UV-Vis spectrum and high accurate mass spectra of the peaks in the sample to those of standard compounds.

In the attached Additional file 1 a detailed analysis of the extracts' components is presented.

Blood samplings and biochemical values

All animals were fasted 12 hours prior to blood sampling. They were mildly sedated (ketamine hydrochloride 12 mg/kg, xylazine 2.5 mg/kg body weight, im) for the procedure in order to avoid stress impact. Blood samples from the auricular artery of animals were placed into Wassermann tubes containing anticoagulant at 0, 1, 2 and 3 months of the experimental procedure. Plasma was separated by centrifugation at 3500 rpm for 15 min. Plasma total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triacylglycerol (TAG) concentrations, serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST) and gamma glutamyl transferase (γGT) activities were measured by commercial enzymatic test kits according to the manufacturer's instructions (Biomerieux, Lyon, France) using an automatic analyser (Type 7170A, Hitachi, Tokyo, Japan). MDA was calculated by the thiobarbituric acid reactive substances (TBARS) manual method as described by Yagi [31]. At the end of the experimental study and after the last blood sampling under sedation, the rabbits were euthanized with sodium thiopental (30 mg/kg iv).

Tissue samples

The aorta was removed from the aortic arch to the iliac bifurcation. The tissues adhering to the adventitia were removed and the aorta was cut longitudinally along the mid-ventral wall. The aorta was then fixed flatly in 10% phosphate buffered formalin solution. The luminal surface of each aortic specimen was photographed and the image was stored electronically. Sections from all specimens were obtained from three standard sites (immediately distal to the branch of the left subclavian artery, at the seventh intercostal artery and immediately posterior to the celiac artery). These samples were embedded in paraffin blocks and stained with hematoxylin-eosin. The histopathologic atherosclerotic lesions of the aorta were classified according to the Stary [32] classification, while thickness and surface area of atherosclerotic lesions in the wall of aortae were semiquantified using an automated image analysis system [33]. In brief, parameters evaluated were: intimal thickening, foam cell accumulation, mononuclear infiltrates, lipid core and fibrous cap formation. Digital images were obtained from the slides by a photomicroscope (Nikon Eclipse 80i, Nikon Corp, Tokyo, Japan) equipped with a digital camera (Nikon DS - 2 MW). All the images were transferred to a PC with the appropriate software (Image ProPlus v. 5.1, Media Cybernetics, MD, USA).

The heart and liver were weighed and fixed in 10% phosphate buffered formalin solution. Standard sections were taken, embedded in paraffin blocks for hematoxylin-eosin, and the myocardium specimens were additionally stained with Masson's trichrome stain.

Myocardial lesions were graded from 0 to 3 regarding interstitial edema, fibrosis and foam cell infiltrates. Liver lesions were classified in four grades as previously described [34], regarding alterations of architecture, fatty infiltration and fibrosis.

Data analyses

Data was expressed as mean values ± standard deviation (SD) as well as median values because of violation of normality. The Kolmogorov-Smirnov test was utilized for normality analysis of the parameters.

To indicate the trend in the first 3 months of treatments the median percentage changes after 1, 2 and 3 months of variables respectively were calculated. Comparison of percentage change from baseline of variables during the observation period and the histopathology variables between the three groups were analyzed using the Kruskal-Wallis test and Mann-Whitney test (pairwise comparisons).

All tests were two-sided, statistical significance was set at p < 0.05. All analyses were carried out using the statistical package SPSS vr 16.00 (Statistical Package for the Social Sciences, SPSS Inc., Chicago, Ill., USA).

Abbreviations

MS: 

Mass Spectrometry

UHPLC: 

Ultra High Performance Liquid Chromatography

LC: 

Liquid Chromatography

DAD: 

Diode Array Detector

ESI: 

Electron Spray Ionization

HRMS: 

High Resolution Mass Spectrometry

TC: 

total cholesterol

LDL-C: 

low-density lipoprotein cholesterol

HDL-C: 

high-density lipoprotein cholesterol

TAG: 

triacylglycerol: MDA: malondialdehyde

ALT: 

alanine aminotransferase

AST: 

aspartate aminotranferase

γ-GT: 

gamma glutamyl transferase

TBARS: 

thiobarbituric acid reactive substances

SD: 

standard deviation

SPSS: 

Statistical Package for the Social Sciences

SDG: 

secoisolariciresinol diglucoside.

Declarations

Acknowledgements

Dr. K. Marinou is grateful to the Greek Ministry of Rural Development and Food for its support and educational leave of absence, and to Professor D.N. Perrea for valuable counselling and support in the study. Dr. Dontas acknowledges the Special Account for Research Grants (no. 70/4/2591) of the National and Kapodistrian University of Athens for its financial support. The authors acknowledge Biostatistician Dr. A. Galanos for the expert statistical analysis of the study and acknowledge the expert assistance of K. Perrea, K. Papadaki, E. Dousi, G. Pantelis, P. Rapos and Z. Mertiri during the experiments.

Authors’ Affiliations

(1)
Laboratory of Experimental Surgery and Surgical Research "Christeas Hall", School of Medicine, University of Athens
(2)
Ministry of Rural Development and Food, Centre of Athens Veterinary Institutes, Agia Paraskevi
(3)
Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, University of Athens
(4)
1st Department of Pathology, School of Medicine, University of Athens
(5)
2nd Department of Propedeutic Surgery, Laiko Hospital, School of Medicine, University of Athens
(6)
Experimental - Research Center ELPEN Pharma
(7)
1st Department of Radiology, Aretaieion University Hospital, School of Medicine, University of Athens
(8)
Laboratory of Biochemistry, Department of Chemistry, University of Athens
(9)
Laboratory for Research of the Musculoskeletal System, School of Medicine, University of Athens

References

  1. Lusis AJ: Atherosclerosis. Nature. 2000, 407: 233-41. 10.1038/35025203PubMed CentralView ArticlePubMedGoogle Scholar
  2. Verschuren WMM, Jacobs DR, Bloemberg BPM, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedeljkovic S, Nissinen A, Toshima H: Serum total cholesterol and long-term coronary heart disease mortality in different cultures Twenty-five-year follow-up of the seven countries study. JAMA. 1995, 274: 131-136. 10.1001/jama.274.2.131View ArticlePubMedGoogle Scholar
  3. Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE: Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007, 297: 499-508. 10.1001/jama.297.5.499View ArticlePubMedGoogle Scholar
  4. Al Suwaidi J, Garratt KN, Berger PB, Rihal CS, Bell MR, Grill DE, Holmes DR: Immediate and one-year outcome of intracoronary stent implantation in small coronary arteries with 2.5-mm stents. Am H Journal. 2000, 140: 898-905. 10.1067/mhj.2000.110936. doi:10.1067/mhj.2000.110936.View ArticleGoogle Scholar
  5. Jørgensen B, Simonsen S, Endresen K, Forfang K, Vatne K, Hansen J, Webb J, Buller C, Goulet G, Erikssen J, Thaulow E: Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary Angioplasty Amlodipine REStenosis Study (CAPARES). J Am Coll Card. 2000, 35 (3): 592-9. 10.1016/S0735-1097(99)00599-9.View ArticleGoogle Scholar
  6. Yanni AE: The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim. 2004, 38: 246-256. 10.1258/002367704323133628View ArticlePubMedGoogle Scholar
  7. Karantonis HC, Antonopoulou S, Perrea DN, Sokolis DP, Theocharis SE, Kavantzas N, Iliopoulos DG, Demopoulos CA: In vivo antiatherogenic properties of olive oil and its constitiuent lipid classes in hyperlipidemic rabbits. Nutr Metab Cardiovasc Dis. 2006, 16: 174-85. doi::10.1016/j.numecd.2005.07.003.View ArticlePubMedGoogle Scholar
  8. Aguilera CM, Ramirez-Tortosa MC, Mesa MD, Ramirez-Tortosa CL, Gil A: Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis. 2002, 162: 335-344. doi:10.1016/S0021-9150(01)00737-7.View ArticlePubMedGoogle Scholar
  9. Prasad K: Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation. 1999, 99: 1355-62.View ArticlePubMedGoogle Scholar
  10. Hatipoglu A, Kanbagli O, Balkan J, Kucuk M, Cevikbas U, Aykac-Toker G, Berkkan H, Uysal M: Hazelnut oil administration reduces aortic cholesterol accumulation and lipid peroxides in the plasma, liver, and aorta of rabbits fed a high- cholesterol diet. Biosci Biotechnol Biochem. 2004, 68 (10): 2050-57. 10.1271/bbb.68.2050View ArticlePubMedGoogle Scholar
  11. Gentile C, Tesoriere L, Butera D, Fazzari M, Monastero M, Allegra M, Livrea MA: Antioxidant activity of Sicilian Pistachio (Pistacia vera L. var. Bronte) Nut Extract and its Bioactive Components. J Agric Food Chem. 2007, 55: 643-648. doi:10.1021/jf062533i.View ArticlePubMedGoogle Scholar
  12. Ren M, Rajendran R, Ning P, Huat BTK, Nam OC, Watt F, Jenner A, Halliwell B: Zinc supplementation decreases the development of atherosclerosis in rabbits. Free Radic Biol Med. 2006, 41: 222-25. doi:10.1016/j.freeradbiomed.2006.03.017.View ArticlePubMedGoogle Scholar
  13. Gonzalez-Santiago M, Martin -Bautista E, Carrero JJ, Fonolla J, Baro L, Bartolome MV, Gil-Loyzaga P, Lopez-Huertas E: One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis. 2006, 188: 35-42. doi:10.1016/j.atherosclerosis.2005.10.022.View ArticlePubMedGoogle Scholar
  14. Hartwell JL: Plants used against cancer: A Survey. 1982, 394-406. Quarterman Publications, Lawrence, MA.Google Scholar
  15. Magiatis P, Melliou E, Skaltsounis AL, Chinou IB, Mitaku S: Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. Chia. Planta Med. 1999, 65: 749-752. 10.1055/s-2006-960856View ArticlePubMedGoogle Scholar
  16. Marone P, Bono L, Leone E, Bona S, Carretto E, Perversi L: Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. J Chemother. 2001, 13: 611-614.View ArticlePubMedGoogle Scholar
  17. Janakat S, Al-Merie H: Evaluation of hepatoprotective effect of Pistacia lentiscus, Phillyrea latifolia and Nicotiana glauca. J Ethnopharmacol. 2002, 83: 135-138. doi:10.1016/S0378-8741(02)00241-6.View ArticlePubMedGoogle Scholar
  18. Andrikopoulos NK, Kaliora AC, Assimopoulou AN, Papageorgiou VP: Biological activity of some naturally Occuring Resins, Gums and Pigments Against in vitro LDL Oxidation. Phytother Res. 2003, 17: 501-507. 10.1002/ptr.1185View ArticlePubMedGoogle Scholar
  19. Kordali S, Cakir A, Zengin H, Duru ME: Antifungal activities of the leaves of three Pistacia species grown in Turkey. Fitoterapia. 2003, 74: 164-167. doi:10.1016/S0367-326X(02)00320-9.View ArticlePubMedGoogle Scholar
  20. Zhao J, Sharma Y, Agarwal R: Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion. Mol Carcinog. 1999, 26 (4): 321-33. 10.1002/(SICI)1098-2744(199912)26:4<321::AID-MC11>3.0.CO;2-9View ArticlePubMedGoogle Scholar
  21. Hernadez Figueroa TT, Rodriguez E, Sanchez Muniz FJ: The green tea, a good choice for cardiovascular disease prevention?. Arch Latinoam Nutr. 2004, 54 (4): 380-94.Google Scholar
  22. Fassbender K, Lütjohann D, Dik MG, Bremmer M, König J, Walter S, Liu Y, Letièmbre M, von Bergmann K, Jonker C: Moderately elevated plant sterol levels are associated with reduced cardiovascular risk--the LASA study. Atherosclerosis. 2008, 196 (1): 283-8. doi:10.1016/j.atherosclerosis.2006.10.032.View ArticlePubMedGoogle Scholar
  23. Appeldoorn CC, Bonnefoy A, Lutters BC, Daenens K, van Berkel TJ, Hoylaerts MF, Biessen EA: Gallic acid antagonizes P-selectin-mediated platelet-leukocyte interactions: implications for the French paradox. Circulation. 2005, 111 (1): 106-12. doi:10.1161/01.CIR.0000151307.10576.02.View ArticlePubMedGoogle Scholar
  24. Kang MH, Kawai Y, Naito M, Osawa T: Dietary defatted sesame flour decreases susceptibility to oxidative stress in hypercholesterolemic rabbits. J Nutr. 1999, 129: 1885-90.PubMedGoogle Scholar
  25. Hakimoglu F, Kizil G, Kanay Z, Kizil M, Isi H: The effect of ethanol extract of Hypericum lysimachoides on lipid profile in hypercholesterolemic rabbits and its in vitro antioxidant activity. Atherosclerosis. 2007, 192: 113-122. doi:10.1016/j.atherosclerosis.2006.07.013.View ArticlePubMedGoogle Scholar
  26. Adibi P, Sadeghi M, Mahsa M, Rozarti G, Mohseni M: Prediction of coronary atherosclerotic disease with liver transaminase level. Liver International. 2007, 27 (7): 895-900. doi:10.1111/j.1478-3231.2007.01545.x.View ArticlePubMedGoogle Scholar
  27. Prasad K: A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex. J Cardiovasc Pharamacol Ther. 2007, 12: 304-13. 10.1177/1074248407307853.View ArticleGoogle Scholar
  28. Kavantzas N, Chatziioannou A, Yanni AE, Tsakayannis D, Balafoutas D, Agrogiannis G, Perrea D: Effect of green tea on angiogenesis and severity of atherosclerosis in cholesterol-fed rabbit. Vasc Pharmacol. 2006, 44: 461-3. 10.1016/j.vph.2006.03.008. doi:10.1016/j.vph.2006.03.008.View ArticleGoogle Scholar
  29. Covas MI: Olive oil and the cardiovascular system. Pharmacological Research. 2007, 55: 175-186. doi: 10.1016/j.phrs.2007.01.010.View ArticlePubMedGoogle Scholar
  30. Perona JS, Cabello-Moruno R, Ruiz-Guttierez V: The role of virgin olive oil components in the modulation of endothelial function. Journal of Nutritional Biochemistry. 2006, 17: 429-445. doi:10.1016/j.jnutbio.2005.11.007.View ArticlePubMedGoogle Scholar
  31. Yagi K: Simple assay for the level of total lipid peroxides in blood plasma. Meth Mol Biol. 1998, 108: 101-6.Google Scholar
  32. Stary HC: Natural history and histological classification of atherosclerotic lesions. An update. Arterioscler Thromb Vasc Biol. 2000, 20: 1177-8.View ArticlePubMedGoogle Scholar
  33. Tsantila N, Karantonis HC, Perrea DN, Theocharis SE Iliopoulos DG, Iatrou C, Antonopoulou S, Demopoulos CA: Atherosclerosis regression study in rabbits upon olive pomace polar lipid extract administration. Nutr Metab Cardiovasc Dis. 2009, doi:10.1016/j.numecd.2009.06.008.Google Scholar
  34. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005, 41: 1313-21. 10.1002/hep.20701View ArticlePubMedGoogle Scholar

Copyright

© Marinou et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement